Literature DB >> 2375782

Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol.

T Hämäläinen1, A Palotie, K Aalto-Setälä, K Kontula, M J Tikkanen.   

Abstract

Familial defective apolipoprotein B-100 is a genetic disorder which is associated with elevated plasma LDL levels. It appears to result from a G----A mutation at nucleotide 10,708 in exon 26 of the apolipoprotein B-100 gene leading to a substitution of glutamine for arginine at amino acid residue 3500. We explored the possible role of this point mutation as a cause of elevated plasma cholesterol among the Finns, a genetically isolated population in which both hypercholesterolemia and coronary heart disease are common: 552 hyperlipidemic patients from Western and Southern Finland were screened either by assaying patient sera with monoclonal antibody MB47 or by amplifying the region of the apo B gene containing the nucleotide 10,708 followed by hybridization of the amplified DNA with allele-specific oligonucleotide probes. Not a single individual with this particular mutation could be found. We conclude that familial defective apo B-100 is not a common cause of elevated plasma cholesterol in this population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375782     DOI: 10.1016/0021-9150(90)90038-k

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  First International Workshop on Familial Defective apo B-100, Munich, November 1991.

Authors:  H Schuster; S Humphries; G Rauh; C Keller
Journal:  Clin Investig       Date:  1992-10

2.  Approach to identification of a point mutation in apo B100 gene by means of a PCR-mediated site-directed mutagenesis.

Authors:  E I Schwartz; S P Shevtsov; A P Kuchinski; O V Plutalov
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

3.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

4.  Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.

Authors:  M Chmara; B Wasag; M Zuk; J Kubalska; A Wegrzyn; M Bednarska-Makaruk; E Pronicka; H Wehr; J C Defesche; A Rynkiewicz; J Limon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

5.  Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction.

Authors:  Y Friedlander; E J Dann; E Leitersdorf
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

6.  Detection of apoB-100 R3500Q mutation by competitive allele-specific polymerase chain reaction.

Authors:  A D Horvath; S A Kirov; E E Karaulanov; V S Ganev
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 7.  Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.

Authors:  G Rauh; C Keller; H Schuster; G Wolfram; N Zöllner
Journal:  Clin Investig       Date:  1992-01

8.  Absence of Apo B R3500Q Mutation among Kelantanese Malays with Hyperlipidaemia.

Authors:  W M Kyi; M N Isa; F A Rashid; J M Osman; M A Mansur
Journal:  Malays J Med Sci       Date:  2000-01

9.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene.

Authors:  U M Koivisto; J S Viikari; K Kontula
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

10.  Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein.

Authors:  A L Catapano; A Corsini; M Mazzotti; A Granata; P Uboldi; F M Maggi; L Romano; C Romano; S Fantappiè; R Fumagalli
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.